Diabetes Mellitus type 1: the impact on quality of life
DOI:
https://doi.org/10.33448/rsd-v12i3.40680Keywords:
Type 1 diabetes mellitus; Chronic disease; Complications of diabetes; Quality of life.Abstract
Diabetes Mellitus is a chronic non-communicable pathology caused by carbohydrate metabolism disorders, the most common forms of presentation of the disease are Diabetes Mellitus Type 1 (DM1) and Type 2 (DM2), Type 1 is characterized by autoimmune disorder by interaction of genetic and environmental factors that triggers an autoimmune reaction against the β-pancreatic cells of the individual making him unable to produce insulin, this disorder appears in the first decade of life and is capable of causing acute and chronic damage to carriers. Thereby, the objective was to study the clinical aspects of DM1, and its consequences in the lives of its carriers. It was verified that the genetic bases of DM1 are related to changes in the human leukocyte antigen responsible for the non-recognition of insular antigens and tissue aggression. Due to the precocity of the symptoms, in addition to the acute repercussions (hypoglycemia and diabetic ketoacidosis), the chronic implications become important, the patients present a longer time of evolution of the pathology and of the alterations caused to the micro and macrocirculation. In DM1, microangiopathic complications are more present, however, other complications are also factors of concern and reduced quality of life and self-care. The main implications of DM1 in the life of its bearer and stress resulting from the treatment, which causes anxiety and non-acceptance of the patient.
References
Abreu, M. C. (2020). Diabetes Mellitus Tipo 1: sinais, sintomas, diagnóstico e repercussão na criança e no adolescente. Repositório de Trabalhos de Conclusão de Curso.
American Diabetes Association. (2020). 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2020. Diabetes care, 43(Supplement_1), S14-S31.
Araújo, C.C., Cunha, C. L. F., Valois, R. C., Botelho, E. P., Barbosa, J. S., & Ferreira, G. R. O. N. (2019). Internações por diabetes mellitus no estado do Pará: distribuição espacial e fatores associados ao óbito. Nursing (São Paulo), 22(257), 3226-3233.
Bak, J.C.G., Serné, E.H., Kramer, M.H.H. et al. National diabetes registries: do they make a difference?. Acta Diabetol. 2021; 58: 267–278.
Balseiro, E. M., Balseiro, L. M., de Oliveira, S. G., & de Godoy Soares, L. M. (2021). Cenários do efeito tardio do diabetes mellitus de 2010 a 2019 no Brasil. Revista Artigos. Com, 27, e6972-e6972.
Camargo, R. L. (2019). NEUROPATIA AUTONÔMICA: UMA MANIFESTAÇÃO DE ALTO RISCO NO DIABETES MELLITUS TIPO 1. Anais do Seminário Científico do UNIFACIG, (5).
Cruz, D. S. M. D., Collet, N., & Nóbrega, V. M. (2018). Qualidade de vida relacionada à saúde de adolescentes com dm1-revisão integrativa. Ciência & Saúde Coletiva, 23, 973-989.
DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018). Type 1 diabetes. The Lancet, 391(10138), 2449-2462.
Faludi, A. A., Izar, M. C. D. O., Saraiva, J. F. K., Bianco, H. T., Chacra, A. P. M., Bertoluci, M. C., ... & Rocha, A. M. D. (2017). Diretriz brasileira baseada em evidências sobre prevenção de doenças cardiovasculares em pacientes com diabetes: posicionamento da Sociedade Brasileira de Diabetes (SBD), da Sociedade Brasileira de Cardiologia (SBC) e da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM). Arquivos brasileiros de cardiologia, 109, 1-31.
Ferreira, D. L., Fonseca, E. C. R., Lucas, A. L. R., Silva, A. C. F., Lenci, S. S., Silva, S. G. F., ... & de Resende, E. A. M. R. (2020). O efeito da orientação preventiva multiprofissional em pacientes com diabetes mellitus. Revista Eletrônica Acervo Saúde, (45), e2381-e2381.
Flor, L. S., & Campos, M. R. (2017). Prevalência de diabetes mellitus e fatores associados na população adulta brasileira: evidências de um inquérito de base populacional. Revista brasileira de epidemiologia, 20, 16-29.
Goethals, E. R., Oris, L., Soenens, B., Berg, C. A., Prikken, S., Van Broeck, N., ... & Luyckx, K. (2017). Parenting and treatment adherence in type 1 diabetes throughout adolescence and emerging adulthood. Journal of pediatric psychology, 42(9), 922-932.
Gomes, L. C., Castelar Tsuda, L., & Pace, A. E. (2020). Conhecimento e práticas de pessoas com diabetes mellitus sobre a terapêutica medicamentosa e suas complicações agudas. Enfermagem Brasil, 19(4).
Greco-Soares, J. P., & Dell’Aglio, D. D. (2017). Adesão ao tratamento em adolescentes com diabetes mellitus tipo 1. Psicologia, Saúde e Doenças, 18(2), 322-334.
Gregory, G. A., Robinson, T. I., Linklater, S. E., Wang, F., Colagiuri, S., de Beaufort, C., & Ogle, G. D. (2022). Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. The Lancet Diabetes & Endocrinology, 10(10), 741-760.
International Diabetes Federation (2019). IDF Diabetes Atlas. (9aed.), Brussels, Belgium: International Diabetes Federation.
Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., ... & Lernmark, Å. (2017). Type 1 diabetes mellitus. Nature reviews Disease primers, 3(1), 1-17.
Macedo, J. L., Oliveira, A. S. D. S. S., Pereira, I. C., Reis, E. R., & Magalhães, M. D. J. S. (2019). Perfil epidemiológico do diabetes mellitus na região nordeste do Brasil. Research, Society and Development, 8(3), 25.
Maciel, R. O., Sant, M. R., Vasconcelos, A., & de Andrade, C. R. (2019). Nefropatia diabética–incidência e fatores de risco associados. Brazilian Journal of Health Review, 2(4), 3808-3823.
Mauricio, D., Alonso, N., & Gratacòs, M. (2020). Chronic diabetes complications: the need to move beyond classical concepts. Trends in Endocrinology & Metabolism, 31(4), 287-295.
Neves, C., Neves, J. S., Oliveira, S. C., Oliveira, A., & Carvalho, D. (2017). Diabetes Mellitus Tipo 1. Revista Portuguesa de Diabetes, 12(4), 159-167.
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., ... & Makaroff, L. E. (2017). IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice, 128, 40-50.
Ramalho, S., & Nortadas, R. (2021). Anticorpos na diabetes mellitus tipo 1. Revista Portuguesa de Diabetes, 16(2), 73-79.
Reyes, X. T., Rodríguez, S. E. L., & Domínguez, J. A. B. (2021). Clinical complications in patients admitted for diabetic foot in the Institute of Angiology. Revista Cubana de Angiología y Cirugía Vascular, 22(1), 1-15.
Simó-Servat, O., Hernández, C., & Simó, R. (2019). Diabetic retinopathy in the context of patients with diabetes. Ophthalmic research, 62(4), 211-217.
Souza, L. C. V. F. D., Kraemer, G. D. C., Koliski, A., Carreiro, J. E., Cat, M. N. L., Lacerda, L. D., & França, S. N. (2019). Cetoacidose diabética como apresentação inicial de diabetes tipo 1 em crianças e adolescentes: estudo epidemiológico no sul do Brasil. Revista Paulista de Pediatria, 38.
Souza, M. T. D., Silva, M. D. D., & Carvalho, R. D. (2010). Revisão integrativa: o que é e como fazer. Einstein (São Paulo), 8, 102-106.
Triolo, T. M., Pyle, L., Broncucia, H., Armstrong, T., Yu, L., Gottlieb, P. A., & Steck, A. K. (2022). Association of high-affinity autoantibodies with type 1 diabetes high-risk HLA haplotypes. The Journal of Clinical Endocrinology & Metabolism, 107(4), e1510-e1517.
Zaremba, N., Watson, A., Kan, C., Broadley, M., Partridge, H., Figuereido, C., ... & Stadler, M. (2020). Multidisciplinary healthcare teams' challenges and strategies in supporting people with type 1 diabetes to recover from disordered eating. Diabetic Medicine, 37(12), 1992-2000.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Agnaldo Saraiva Leitão Filho; Gabriella Gil Aguila Saraiva Leitão; Pedro Elson Silva dos Santos; Ana Elisa Rebeschini De Marchi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
